Abstract:In higher vertebrates, mucosal sites at the border between the internal and external environments, directly interact with bacteria, viruses, and fungi. Through co-evolution, hosts developed mechanisms of tolerance or ignorance toward some infectious agents, because hosts established "gain of function" interactions with symbiotic bacteria. Indeed, some bacteria assist hosts in different functions, among which are digestion of complex carbohydrates, and absorption and supply of vitamins. There is no doubt that microbiota modulate innate and acquired immune responses starting at birth. However, variations in quality and quantity of bacterial species interfere with the equilibrium between inflammation and tolerance. In fact, correlations between gut bacteria composition and the severity of inflammation were first described for inflammatory bowel diseases and later extended to other pathologies. The genetic background, environmental factors (e.g., stress or smoking), and diet can induce strong changes in the resident bacteria which can expose the intestinal epithelium to a variety of different metabolites, many of which have unknown functions and consequences. In addition, alterations in gut permeability may allow pathogens entry, thereby triggering infection and/or chronic inflammation. In this context, a local event occurring at a mucosal site may be the triggering cause of an autoimmune reaction that eventually involves distant sites or organs. Recently, several studies attributed a pathogenic role to altered oral microbiota in rheumatoid arthritis (RA) and to gut dysbiosis in spondyloarthritis (SpA). There is also growing evidence that different drugs, such as antibiotics and immunosuppressants, can influence and be influenced by the diversity and composition of microbiota in RA and SpA patients. Hence, in complex disorders such RA and SpA, not only the genetic background, gender, and immunologic context of the individual are relevant, but also the history of infections and the structure of the microbial community at mucosal sites should be considered. Here the role of the microbiota and infections in the initiation and progression of chronic arthritis is discussed, as well as how these factors can influence a patient's response to synthetic and biologic immunosuppressive therapy.

Gut microbiota as a sensor of autoimmune response and treatment for rheumatoid arthritis

Bugs & us: the role of the gut in autoimmunity

Arthritis susceptibility and the gut microbiome

The role of the microbiome in rheumatoid arthritis: a review

Exploring the Role of the Microbiome in Rheumatoid Arthritis-A Critical Review

Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance

Exploring the significance of microbiota metabolites in rheumatoid arthritis: uncovering their contribution from disease development to biomarker potential

Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis

Role of Gut Microbiota in the Development and Management of Rheumatoid Arthritis: A Narrative Review

Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis

Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis

The rheumatoid arthritis gut microbial biobank reveals core microbial species that associate and effect on host inflammation and autoimmune responses

Role of Intestinal Microbiota on Gut Homeostasis and Rheumatoid Arthritis

The gut–joint axis in rheumatoid arthritis

Treatment response in rheumatoid arthritis is predicted by the microbiome: a large observational study in UK DMARD-naive patients

Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis

The impact of the human gut microbiome on the treatment of autoimmune disease

The role of microbiota on rheumatoid arthritis onset

Targeting Probiotics in Rheumatoid Arthritis

Role of Intestinal Dysbiosis and Nutrition in Rheumatoid Arthritis

Role of gut microbiota in rheumatoid arthritis: potential cellular mechanisms regulated by prebiotic, probiotic, and pharmacological interventions